Status:
RECRUITING
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Skin Neoplasm
Skin Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a no...
Detailed Description
PRIMARY OBJECTIVE: I. To perform a first-in-human study to assess the ability of a qOBM handheld device to reliably image skin pathology in-situ and in-vivo. SECONDARY OBJECTIVES: I. Characterize a...
Eligibility Criteria
Inclusion
- Male or Female
- Candidate with skin lesions
- Signed study-specific informed consent prior to study entry
- ≥ 18 years old
Exclusion
- Prior surgery or radiotherapy to the area to be treated
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 17 2027
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT07213154
Start Date
October 15 2025
End Date
September 17 2027
Last Update
December 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
2
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States, 30322